| Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein GDJ Watts, J Wymer, MJ Kovach, SG Mehta, S Mumm, D Darvish, ... Nature genetics 36 (4), 377-381, 2004 | 1646 | 2004 |
| Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS HJ Kim, NC Kim, YD Wang, EA Scarborough, J Moore, Z Diaz, ... Nature 495 (7442), 467-473, 2013 | 1636 | 2013 |
| Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis JD Rothstein, G Tsai, RW Kuncl, L Clawson, DR Cornblath, DB Drachman, ... Annals of neurology 28 (1), 18-25, 1990 | 872 | 1990 |
| A randomized study of alglucosidase alfa in late-onset Pompe's disease AT Van der Ploeg, PR Clemens, D Corzo, DM Escolar, J Florence, ... New England Journal of Medicine 362 (15), 1396-1406, 2010 | 830 | 2010 |
| TDP‐43 A315T mutation in familial motor neuron disease MA Gitcho, RH Baloh, S Chakraverty, K Mayo, JB Norton, D Levitch, ... Annals of Neurology: Official Journal of the American Neurological …, 2008 | 774 | 2008 |
| A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside A Pestronk, DR Cornblath, AA Ilyas, H Baba, RH Quarles, JW Griffin, ... Annals of Neurology: Official Journal of the American Neurological …, 1988 | 766 | 1988 |
| An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study TM Miller, A Pestronk, W David, J Rothstein, E Simpson, SH Appel, ... The Lancet Neurology 12 (5), 435-442, 2013 | 720 | 2013 |
| A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy KR Wagner, JL Fleckenstein, AA Amato, RJ Barohn, K Bushby, ... Annals of neurology 63 (5), 561-571, 2008 | 631 | 2008 |
| Myasthenia gravis: study of humoral immune mechanisms by passive transfer to mice KV Toyka, DB Drachman, DE Griffin, A Pestronk, JA Winkelstein, ... New England Journal of Medicine 296 (3), 125-131, 1977 | 574 | 1977 |
| Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations RH Baloh, RE Schmidt, A Pestronk, J Milbrandt Journal of Neuroscience 27 (2), 422-430, 2007 | 561 | 2007 |
| Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis JO Johnson, EP Pioro, A Boehringer, R Chia, H Feit, AE Renton, ... Nature neuroscience 17 (5), 664-666, 2014 | 554 | 2014 |
| Myasthenia gravis: passive transfer from man to mouse KV Toyka, DB Brachman, A Pestronk, I Kao Science 190 (4212), 397-399, 1975 | 551 | 1975 |
| Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS T Miller, M Cudkowicz, PJ Shaw, PM Andersen, N Atassi, RC Bucelli, ... New England Journal of Medicine 383 (2), 109-119, 2020 | 542 | 2020 |
| 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14–16 October 2016 Y Allenbach, AL Mammen, O Benveniste, W Stenzel, A Amato, A Aussey, ... Neuromuscular disorders 28 (1), 87-99, 2018 | 531 | 2018 |
| Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study CM McDonald, EK Henricson, RT Abresch, T Duong, NC Joyce, F Hu, ... The Lancet 391 (10119), 451-461, 2018 | 501 | 2018 |
| Peripheral nerve size in normals and patients with polyneuropathy: an ultrasound study CM Zaidman, M Al‐Lozi, A Pestronk Muscle & Nerve: Official Journal of the American Association of …, 2009 | 403 | 2009 |
| Myopathy with antibodies to the signal recognition particle: clinical and pathological features T Miller, MT Al-Lozi, G Lopate, A Pestronk Journal of Neurology, Neurosurgery & Psychiatry 73 (4), 420-428, 2002 | 393 | 2002 |
| Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort KM Flanigan, DM Dunn, A Von Niederhausern, P Soltanzadeh, ... Human mutation 30 (12), 1657-1666, 2009 | 384 | 2009 |
| Prednisone in Duchenne dystrophy: a randomized, controlled trial defining the time course and dose response RC Griggs, RT Moxley, JR Mendell, GM Fenichel, MH Brooke, A Pestronk, ... Archives of neurology 48 (4), 383-388, 1991 | 368 | 1991 |
| Long‐term benefit from prednisone therapy in Duchenne muscular dystrophy GM Fenichel, JM Florence, A Pestronk, JR Mendell, RT Moxley III, MD, ... Neurology 41 (12), 1874-1874, 1991 | 359 | 1991 |
